Prosecution Insights
Last updated: October 02, 2026

Examiner: RADOMSKI, MARTIN ADAM

Tech Center 3700 • Art Units: 3783 3799

This examiner grants 32% of resolved cases

Analysis

Martin Adam Radomski serves in Tech Center 3700 and Art Unit 3783. The examiner has a total of 31 resolved cases. The allowance rate for these cases is 32.3%. This 32.3% rate provides a metric for the likelihood of obtaining a patent grant under this examiner's review. Applicants can evaluate their prosecution strategy based on this frequency of outcomes.

The interview lift is 55.7%. This 55.7% lift suggests that engaging in a direct dialogue with the examiner is associated with an increase in the probability of allowance. The 55.7% lift indicates that an interview is a documented tool for advancing the case. The median days to allowance is 1319. This 1319 day duration represents the middle point of the time required to reach a grant, helping practitioners manage expectations regarding the length of the patent acquisition process. The 1319 days serve as a benchmark for planning in Art Unit 3783.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

32.3%
Allow Rate
-37.7% vs TC avg
85
Total Applications
+55.7%
Interview Lift
1319
Avg Prosecution Days
Based on 31 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
21.9%
§102 Novelty
58.0%
§103 Obviousness
18.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17648868 MEDICAL DELIVERY DEVICE AND METHODS OF USING THE SAME Final Rejection Boston Scientific Scimed, Inc.
18145450 Integrated Hemostasis Bypass Valve Final Rejection St. Jude Medical, Cardiology Division, Inc.
18791826 MEDICAL APPARATUS Non-Final OA CANON KABUSHIKI KAISHA
17773636 BREAST PUMP SYSTEM Final Rejection KONINKLIJKE PHILIPS N.V.
18088871 SYSTEMS AND METHODS FOR EMBOLIZATION PROCEDURES FOR TREATMENT OF DEFECTS IN THE VASCULATURE Final Rejection DePuy Synthes Products, Inc.
17899031 INTRAVENOUS TUBING UPPER FITMENT Final Rejection CareFusion 303, Inc.
18478047 Integrated Catheter with Needle-Free Connector Final Rejection Becton, Dickinson and Company
18033772 CATHETER ASSEMBLY PLUG DEVICES, SYSTEMS, AND METHODS Final Rejection Becton, Dickinson and Company
17898617 Integrated Catheter with Needle-Free Connector Final Rejection Becton, Dickinson and Company
17860487 Insertion Mechanism with Automatic Activation Non-Final OA Becton, Dickinson and Company
17781940 A Drug Delivery Device Final Rejection Sanofi
17883909 MEDICAL ELONGATED BODY Final Rejection TERUMO KABUSHIKI KAISHA
17638459 SYSTEMS AND METHODS FOR POST-OCCLUSION BOLUS REDUCTION Final Rejection ICU Medical, Inc.
18846367 SUB-ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICE Non-Final OA SHL Medical AG
18729948 Sub-assembly for a medicament delivery device Non-Final OA SHL Medical AG
18222846 APPARATUS AND METHODS FOR ADMINISTRATION OF MEDICINE INCLUDING MONITORING AND USER FEEDBACK Non-Final OA SHL MEDICAL AG
18119982 APPARATUS AND METHODS FOR ADMINISTRATION OF MEDICINE INCLUDING MONITORING AND USER FEEDBACK Non-Final OA SHL MEDICAL AG
18032765 DRUG DELIVERY DEVICE ASSEMBLY AND ACCESSORY FOR DRUG DELIVERY DEVICE Non-Final OA AMGEN INC.
16898628 DRUG DELIVERY DEVICE WITH A ROTATABLE DRIVE MECHANISM Non-Final OA AMGEN INC.
18037781 An Anal Probe Non-Final OA Coloplast A/S
18037780 Liquid container for an Anal Irrigation System Final Rejection Coloplast A/S
18037779 A PORTABLE BOWEL IRRIGATION SYSTEM AND A METHOD OF IRRIGATION OF THE BOWELS OF A USER Final Rejection Coloplast A/S
18029422 MEDICAL PORT PROTECTION ADAPTERS Final Rejection Thomas Jefferson University
18028688 Medical Pump for Endoscopy Non-Final OA W.O.M. World of Medicine GmbH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month